Work

Phase I trial of cetuximab, intensity modulated radiotherapy (IMRT), and the anti-CTLA-4 monoclonal antibody (mAb) ipilimumab in previously untreated, locally advanced head and neck squamous cell carcinoma (PULA HNSCC).

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.tps6104

Authors: Julie E. Bauman, William E. Gooding, David Andrew Clump, Seungwon Kim, Brian J Karlovits, Dwight Earl Heron, Umamaheswar Duvvuri, James Ohr, Karen Holeva, Robert L. Ferris

Institutions: UPMC Hillman Cancer Center, University of Pittsburgh, University of Pittsburgh Medical Center

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2599396226

Cites:

Cited by: 11

Related to: 10